Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Treatments
Find Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Treatments
Medications for Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).
Found 1 Approved Drug for Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Tolvaptan
Brand Names
Jynarque, Samsca
Tolvaptan
Brand Names
Jynarque, Samsca
Form: Tablet, Kit
Method of administration: Oral
FDA approval date: May 19, 2009
Classification: Vasopressin V2 Receptor Antagonist
JYNARQUE is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). JYNARQUE is a selective vasopressin V 2 -receptor antagonist indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD) ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances